Home › Amgen buying cancer drug maker Onyx for $10.4B
 

Keywords :   


Amgen buying cancer drug maker Onyx for $10.4B

2013-08-27 15:03:04| Chemicals - Topix.net

Biotech drugmaker Amgen will buy cancer drug maker Onyx Pharmaceuticals for about $10.4 billion in cash in a deal that will add several cancer drugs to Amgen's stable and boost its pipeline of new drugs.

Tags: drug buying cancer maker

Category:Chemicals

Latest from this category

All news
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
Chemicals »
25.11 ADIDAS adizero adios pro3 27.0
25.11
25.11
25.113
25.11225 5-P
25.11PC
25.11GODZILLA 1954
25.11 1~26
More »